Short Interest Ratio: 37.66

good company

21.5

22.5

From a recent Mad Money show:"In this new environment, I need stocks to have a good dividend, be near liquidation value or be recession resistant, and that one has none of those."

From a recent Mad Money show:"In this new environment, I need stocks to have a good dividend, be near liquidation value or be recession resistant, and that one has none of those."

Market Outperform - Price 35.69 on Jan. 6
by Avondale Partners

[This animal-health lab firm specializes] in bench-top analyzers, rapid assays, herd/food animal diagnostics, and drinking-water testing....Its strong market position and presence in these categories allows for greater adoption of new technology and products through established sales channels....Our 44 target is derived by using a 22 times P/E multiple and applying it to our 2010 EPS estimate of $2.21, and discounting it 10%...[which we believe] appropriate, given Idexx's leading market position and track record of growing earnings between 15% and 20% the last five years. We look for that growth to continue, even after the company passes the $1 billion mark in revenues this year. The two analyzers Catalyst Dx and SNAPshot comprise high-profile product launches....Market cap: $2 billion.

8 am

26.7

From a recent Mad Money show:

"This company is a classic good name that should be bought on dips. It's a long-term theme and I'd stick with it."

Health care